Impact of Pharmacist-Led Intervention on Adherence, Quality of Life, and Self-efficacy Among Iraqi Patients with Systemic Lupus Erythematosus
DOI:
https://doi.org/10.54133/ajms.v8i2.2038Keywords:
Adherence, Pharmacist, Quality of life, Systemic lupus erythmatosus, Self-efficacyAbstract
Background: The prevalence of systemic lupus erythematosus (SLE) patients is rising in Iraq. Adherence to medications among SLE patients remains a significant problem, and nonadherence can lead to decreased quality of life (QoL) and poor disease outcomes. Objectives: To determine the efficacy of pharmacist interventions in enhancing medication adherence, QoL, and self-efficacy among SLE patients. In addition, to assess the influence of pharmacist intervention on the uptake and willingness to take the flu vaccine among patients with SLE. Methods: A pharmacist intervention study was conducted at the Rheumatology Unit in Baghdad Teaching Hospital. Participants obtained educational counseling and a self-assembled booklet. Each patient participated in two sessions; the initial session was conducted immediately after the completion of a baseline evaluation of adherence, QoL, and self-efficacy through a face-to-face interview, and the second session was held one month later. Each session continued for approximately 25-35 minutes. The evaluation of adherence, QoL, and self-efficacy was obtained again at the end of the study. Results: The study recruited 90 patients with a mean age of 34.29±9.9 years. The mean scores of adherence, physical, social, and psychological domains of QoL, and self-efficacy were significantly enhanced after the intervention. Still, the environmental domain of quality of life is non-significantly changed. Also, after the intervention, a significant rise was seen in the uptake and willingness to take the flu vaccine. Conclusion: Pharmacist-led intervention significantly improved medication adherence, quality of life, self-efficacy, and the uptake and willingness to take the flu vaccine among SLE patients.
Downloads
References
Barber MRW. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515-532. doi: 10.1038/s41584-021-00668-1. DOI: https://doi.org/10.1038/s41584-021-00668-1
Al-rawi Z, Al-shaarbaf H, Al-raheem E, Khalifa SJ. Clinical features of early cases of systemic lupus erythematosus in Iraqi patients. Rheumatology. 1983;22(3):165–171. doi: 10.1093/rheumatology/22.3.165. DOI: https://doi.org/10.1093/rheumatology/22.3.165
Burkhart PV, Sabaté E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35(3):207. DOI: https://doi.org/10.1111/j.1547-5069.2003.tb00001.x
Emamikia S, Gomez A, Ådahl T, von Perner G, Enman Y, Chatzidionysiou K, et al. Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey. Lupus. 2024;33(6):615–628. doi: 10.1177/09612033241242692. DOI: https://doi.org/10.1177/09612033241242692
Abbas HK, Kadhim DJ, Gorial FI, Shareef LG. Assessment of medication-related burden among a sample of Iraqi patients with systemic lupus erythematosus and its relationship with disease activity: a cross-sectional study. F1000Research. 2022;11:970. doi: 10.12688/f1000research.124698.1. DOI: https://doi.org/10.12688/f1000research.124698.2
Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28(3):551–558. doi: 10.1017/s0033291798006667. DOI: https://doi.org/10.1017/S0033291798006667
De Souza RR, Marcon SS, Teston EF, dos Reis P, de Souza Campos Seguraço R, Silva ES, et al. Factors influencing quality of life in people with systemic lupus erythematosus. ACTA Paul Enferm. 2021;34:1–10. doi: 10.37689/acta-ape/2021AO01173. DOI: https://doi.org/10.37689/acta-ape/2021AO01173
Ali AS, Mikhael EM, Mohammed SI. Evaluating stress level and its effect on the quality of life among pharmacists working in Baghdad teaching hospitals. Al-Rafidain J Med Sci. 2025;8:92–96. doi: 10.54133/ajms.v8i1.1661. DOI: https://doi.org/10.54133/ajms.v8i1.1661
Bandura A, Freeman WH, Lightsey R. Self-efficacy: The exercise of control. J Cognit Psychother. 1999;13:158–166. doi: 10.1891/0889-8391.13.2.158. DOI: https://doi.org/10.1891/0889-8391.13.2.158
Ugarte-Gil MF, Gamboa-Cardenas RV, Reátegui-Sokolova C, Pimentel-Quiroz VR, Medina M, Elera-Fitzcarrald C, et al. A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort. Lupus Sci Med. 2023;10(1). doi: 10.1136/lupus-2022-000874. DOI: https://doi.org/10.1136/lupus-2022-000874
Chen Y, Chen B, Shen X, Zhou A, Liang Y, Wang Y, et al. A survey of systemic lupus erythematosus patients’ attitudes toward influenza and pneumococcal vaccination in Southwest China. Front Public Health. 2022;10:1018899. doi: 10.3389/fpubh.2022.1018899. DOI: https://doi.org/10.3389/fpubh.2022.1018899
Villaverde Piñeiro L, Cachafeiro Pin AI, Tajes González YM, Neira Blanco P, Arias Fernández L, Vázquez López M, et al. Impact of a pharmaceutical intervention on influenza vaccination in patients receiving treatment with biological medicines. Eur J Hosp Pharm Sci Pract. 2023;31(1):36–39. doi: 10.1136/ejhpharm-2021-003175. DOI: https://doi.org/10.1136/ejhpharm-2021-003175
Oliveira-Santos M, Verani JFS, Camacho LAB, de Andrade CAF, Klumb EM. Effectiveness of pharmaceutical care for drug treatment adherence in women with lupus nephritis in Rio de Janeiro, Brazil: a randomized controlled trial. Lupus. 2019;28(11):1368–1377. doi: 10.1177/0961203319877237. DOI: https://doi.org/10.1177/0961203319877237
Sah SK, Ramaswamy S, Ramesh M. Impact of clinical pharmacist interventions in resolving drug-related problems in patients with systemic autoimmune disorders. J Pharmacol Pharmacother. 2021;12(4):168–171. doi: 10.4103/jpp.jpp_149_21.
Mikhael EM, Hassali MA, Hussain SA, Nouri AI, Shawky N. Pharmacist-led interventional programs for diabetic patients in Arab countries: A systematic review study. Int J Diabetes Dev Countries. 2019;39(4):600–610. doi: 10.1007/s13410-019-00720-7. DOI: https://doi.org/10.1007/s13410-019-00720-7
Mohammed I. Impact of clinical pharmacist intervention on chemotherapy knowledge, attitude , and practice among breast cancer women. J Fac Med Baghdad. 2024;66(1):103–109. doi: 10.32007/jfacmedbagdad.6612221. DOI: https://doi.org/10.32007/jfacmedbagdad.6612221
Mohammed SI, Al-Shadedi MI, Kasim AA. Knowledge, use and recommendation of Iraqi pharmacist toward complementary and alternative medicine. Iraqi J Pharm Sci. 2020;29(1):88–93. doi: 10.31351/vol29iss1pp88-93. DOI: https://doi.org/10.31351/vol29iss1pp88-93
Mohammed SI, Dawood EB, Abaas IS. Perceptions and attitudes of community pharmacists’ towards patient counseling and continuing pharmacy education programs in Iraq. Iraqi J Pharm Sci. 2019;28(2):30–36. doi: 10.31351/vol28iss2pp30-36. DOI: https://doi.org/10.31351/vol28iss2pp30-36
Emamikia S, Gentline C, Enman Y, Parodis I. How can we enhance adherence to medications in patients with systemic lupus erythematosus? Results from a qualitative study. J Clin Med. 2022;11(7). doi: 10.3390/jcm11071857. DOI: https://doi.org/10.3390/jcm11071857
Zhang L, Geng S, Qian L, Ye S, Wang X, Lu G, et al. Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China. Int J Clin Pharm. 2019;41(5):1247–1255. doi: 10.1007/s11096-019-00870-y. DOI: https://doi.org/10.1007/s11096-019-00870-y
Kelly WN, Ho MJ, Smith T, Bullers K, Kumar A. Association of pharmacist intervention counseling with medication adherence and quality of life: A systematic review and meta-analysis of randomized trials. J Am Pharm Assoc. 2023;63(4):1095–1105. doi: 10.1016/j.japh.2023.04.024. DOI: https://doi.org/10.1016/j.japh.2023.04.024
Barr AC, Clowse M, Maheswaranathan M, Eder L, Eudy AM, Criscione-Schreiber LG, et al. Association of hurried communication and low patient self-efficacy with persistent nonadherence to lupus medications. Arthritis Care Res (Hoboken). 2023;75(1):69–75. doi: 10.1002/acr.25030. DOI: https://doi.org/10.1002/acr.25030
Oliveira-Santos M, Verani JF de S, Camacho LAB, de Andrade CAF, Ferrante-Silva R, Klumb EM. Effectiveness of pharmaceutical care for drug treatment adherence in patients with systemic lupus erythematosus in Rio de Janeiro, Brazil: Study protocol for a randomized controlled trial. Trials. 2016;17(1):181. doi: 10.1186/s13063-016-1317-1. DOI: https://doi.org/10.1186/s13063-016-1317-1
Ziadé N, Karam G, Salloum N, Zoghbi M. Transcultural adaptation and validation of the Arabic version of the compliance questionnaire for rheumatology. Acta Sci Orthopaed. 2020;3(10):26–34. doi: 10.31080/ASOR.2020.03.0215. DOI: https://doi.org/10.31080/ASOR.2020.03.0215
WHOQOL - Measuring Quality of Life| The World Health Organization. United Nations ESCAP. Who. 2017:1–19
Sarhan SA, Kamal DE, Hamed MS, Mostafa DI. Validity and reliability of the Arabic version of the Self-Efficacy for Managing Chronic Disease scale in rheumatoid arthritis patients. Clin Rheumatol. 2022;41(10):2967–7295. doi: 10.1007/s10067-022-06183-2. DOI: https://doi.org/10.1007/s10067-022-06183-2
Al-Ameen TM, Al-Metwali BZ. Assessment of adherence and self-efficacy in a sample of Iraqi patients receiving warfarin or direct oral anticoagulants. Al-Rafidain J Med Sci. 2024;6(1):25–33. doi: 10.54133/ajms.v6i1.437. DOI: https://doi.org/10.54133/ajms.v6i1.437
Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001;4(6):256–262.
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35(6):630–640. doi: 10.1002/art.1780350606. DOI: https://doi.org/10.1002/art.1780350606
Rawi ZS Al, Mohammed NA, Ibrahim HA. Factors influencing medication adherence among female patients with systemic lupus erythematosus in Iraq. Int J Sci Res. 2024;13(12):1014–1021. doi: 10.21275/SR241213171931. DOI: https://doi.org/10.21275/SR241213171931
Mohammed RS, Al-jobori SS, Altemimi ZH. Quality of life among patients with systemic lupus erythematosus and its association with sociodemographic and clinical parameters in Karbala governorate. Karbala J Med. 2024;2746–2754. doi: 10.70863/karbalajm.v17i2.1951. DOI: https://doi.org/10.70863/karbalajm.v17i2.1951
Mahmoud H, Abdel Hamid Hawash M, Abd Elmaksoud M. Factors Affecting Adherence of Medication for Patients with Systemic Lupus Erythematous. Egypt J Heal Care. 2022;13(3):1–17. doi: 10.21608/ejhc.2022.249350. DOI: https://doi.org/10.21608/ejhc.2022.249350
Ganachari MS, Almas SA. Evaluation of clinical pharmacist mediated education and counselling of systemic lupus erythematosus patients in tertiary care hospital. Indian J Rheumatol. 2012;7(1):7–12. doi: 10.1016/S0973-3698(12)60003-X. DOI: https://doi.org/10.1016/S0973-3698(12)60003-X
Sah SK, Subramanian R, Ramesh M, Chand S. Impact of pharmacist care in the management of autoimmune disorders: A systematic review of randomized control trials and non-randomized studies. Res Social Adm Pharm. 2021;17(9):1532-1545. doi: 10.1016/j.sapharm.2020.12.005. DOI: https://doi.org/10.1016/j.sapharm.2020.12.005
Sah S, Madhan R, Subramanian R. Initiation of clinical pharmacist services for identification and resolution of drug related problems and detecting their predictors in systemic lupus erythematosus. Value Heal. 2020;23:S746–747. DOI: https://doi.org/10.1016/j.jval.2020.08.2031
Yip SWY, Chong GCH. The role and responsibility of clinical pharmacists in rheumatology clinic: An exploratory study in Hong Kong. Asia Pacific J Heal Manag. 2020;15(2):1–6. doi: 10.24083/apjhm.v15i2.391. DOI: https://doi.org/10.24083/apjhm.v15i2.391
Conti L, Wirth F, Azzopardi L, Mallia C, Vassallo F, Coleiro FC, et al. Pharmaceutical care aspects in systemic lupus erythematosus. Hosp Pharm Eur. 2009;43:48–51.
Abdelrahman BM, Fathy AT, Sabry SS. Effect of continuous care model on self-care practices and quality of life of patients with systemic lupus erythematosus. Egypt J Nurs Health Sci. 2023;4(2):205–232. doi: 10.21608/ejnhs.2023.319002. DOI: https://doi.org/10.21608/ejnhs.2023.319002
Setiawati MCN, Kertia N, Puspitaningrum I. Systemic Lupus erythematosus outpatients medication knowledge and quality of life. J Pharm Sci Clin Res. 2023;8(1):106. doi: 10.20961/jpscr.v8i1.65344. DOI: https://doi.org/10.20961/jpscr.v8i1.65344
Shareef J, Kripa GS, Baikunje S. Impact of pharmacists’ counseling on quality of life in patients undergoing hemodialysis in a tertiary care teaching hospital. World J Nephrol Urol. 2014;3:143–150. doi: 10.14740/wjnu188w. DOI: https://doi.org/10.14740/wjnu188w
Alkashaf KH, Mohammed SI. Impact of clinical pharmacist-led interventions on short term quality of life among breast cancer women taking chemotherapy. Iraqi J Pharm Sci. 2024;33(4):166–173. doi: 10.31351/vol33iss4pp166-173. DOI: https://doi.org/10.31351/vol33iss4pp166-173
Azmi NL, Ahmad SS, Sia R, Lin G, Nur T, Ku E, et al. Impact of educational aid in pharmacist counselling on quality of life in psoriasis patients. Diabetes Metab Syndr Obes. 2019;2(2):48–51. doi: 10.2147/DMSO.S232958. DOI: https://doi.org/10.2147/DMSO.S232958
Omar H, Mohammed H, Ali N, Adel M. The Impact of pharmaceutical care services on patients with active rheumatoid arthritis: A randomized controlled study. Arch Pharm Sci Ain Shams Univ. 2022;6(1):141–155. doi: 10.21608/aps.2022.143040.1092. DOI: https://doi.org/10.21608/aps.2022.143040.1092
Bahap-Kara M, Sariyildiz E, Yardimci GK, Karadag O, Bayraktar-Ekincioglu A. Addressing glucocorticoid-related problems with the clinical pharmacist collaboration in rheumatology practice: A prospective follow-up study. Rheumatol Ther. 2024;11(4):1043–1055. doi: 10.1007/s40744-024-00692-z. DOI: https://doi.org/10.1007/s40744-024-00692-z
Ahmed RA, Ahmed W, Ali S, Mohamed SN. Effect of self-care guidelines on health outcomes and self-efficacy among patients with systemic lupus erythematosus. Egypt J Nurs Health Sci. 2023;4(2):286–327. doi: 10.21608/ejnhs.2023.319235. DOI: https://doi.org/10.21608/ejnhs.2023.319235
Kankaya H, Karadakovan A. Effects of web-based education and counselling for patients with systemic lupus erythematosus: self-efficacy, fatigue and assessment of care. Lupus. 2020;29(8):884–891. doi: 10.1177/0961203320928423. DOI: https://doi.org/10.1177/0961203320928423
Barat E, Soubieux A, Brevet P, Gerard B, Vittecoq O, Lequerre T, et al. Impact of the clinical pharmacist in rheumatology practice: A systematic review. Healthcare. 2024;12(15):1463. doi: 10.3390/healthcare12151463. DOI: https://doi.org/10.3390/healthcare12151463
Sim JJL, Lim CC. Influenza vaccination in systemic lupus erythematosus: Efficacy, effectiveness, safety, utilization, and barriers. Am J Med. 2022;135(3):286-296.e9. doi: 10.1016/j.amjmed.2021.08.038. DOI: https://doi.org/10.1016/j.amjmed.2021.08.038
Le LM, Veettil SK, Donaldson D, Kategeaw W, Hutubessy R, Lambach P, et al. The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis. J Am Pharm Assoc. 2022;62(5):1499-1513.e16. doi: 10.1016/j.japh.2022.06.008. DOI: https://doi.org/10.1016/j.japh.2022.06.008
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Published by Al-Rafidain University College. This is an open access journal issued under the CC BY-NC-SA 4.0 license (https://creativecommons.org/licenses/by-nc-sa/4.0/).
